Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 46, Issue 6, 2005, Pages 833-841

  Savaşan, Süreyya ^a   Buck, Steven ^a   Özdemir, Öner ^a   Hamre, Merlin ^a   Asselin, Barbara ^b   Pullen, Jeannette ^c   Ravindranath, Yaddanapudi ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Apoptosis; Drug sensitivity; Flow cytometry; Lymphoblastic leukemia; MTT; T cell

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTARABINE; DAUNORUBICIN; MICROSOMAL AMINOPEPTIDASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL ASSAY; CELL INTERACTION; CELL SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG RESPONSE; DRUG SENSITIVITY; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REPRODUCIBILITY; RISK ASSESSMENT; T CELL LEUKEMIA; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 21844472982     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500079951     Document Type: Article

References (24)

1. Pieters R, Kaspers GJ, Klumper E, Veerman AJ. Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art. Med Pediatr Oncol 1994;22:299-308.
2. Kaspers GJ, Veerman AJ, Pieters R, et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 1997;90:2723-2729.
3. Kaspers GJ, Pieters R, Van Zantwijk CH, Van Wering ER, Veerman AJ. Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells. Leuk Lymphoma 1995;19:407-416.
4. Hongo T, Yajima S, Sakurai M, Horikoshi Y, Hanada R. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood 1997;89:2959-2565.
5. Schmiegelow K, Nyvold C, Seyfarth J, et al. Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance. Leukemia 2001;15:1066-1071.
6. Grant S. Ara-C: cellular and molecular pharmacology. Adv Cancer Res 1998;72:197-233.
7. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995;82:405-414.
8. Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood 1997;89:1845-1853.
9. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth 1995; 184:39-51.
10. Ormerod MG. The study of apoptotic cells by flow cytometry. Leukemia 1998;12:1013-1025.
11. Savasan S, Buck S, Wei W-Z, Ravindranath Y. Drug induced apoptosis in-vitro as a measure of drug sensitivity in acute leukemia. 3rd International Symposium on Drug Resistance in leukemia and Lymphoma, Amsterdam, The Netherlands, March 4-7, 1998. Leukemia 1998;12:279.
12. Savasan S, Buck S, Becton D, Weinstein H, Ravindranath Y. Cytotoxicity assessment by quantitating drug-induced apoptosis and drug resistance patterns in childhood acute myeloid leukemia (AML). 41st American Society of Hematology Meeting, New Orleans, LA, December 3-7, 1999. Blood 1999;94(suppl 1):63a.
13. Willman CL, Stewart CC. General principles of multiparameter flow cytometric analysis: applications of flow cytometry in the diagnostic pathology laboratory. Semin Diagn Pathol 1989;6:3-12.
14. Terstappen LW, Johnson D, Mickaels RA, et al. Multi-dimensional flow cytometric blood cell differentiation without erythrocyte lysis. Blood Cells 1991;17:585-605.
15. Capizzi RL, White JC, Powell BL, Perrino F. Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytarabine. Semin Hematol 1991;28(3 Suppl 4):54-69.
16. Taub JW, Matherly LH, Stout ML, Buck SA, Gurney JG, Ravindranath Y. Enhanced metabolism of 1-beta-D-arabino-furanosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia. Blood 1996;87:3395-3403.
17. Schorin MA, Blattner S, Gelber RD, et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J Clin Oncol 1994;12:740-747.
18. Amylon MD, Shuster J, Pullen J, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia 1999;13:335-342.
19. Pullen J, Shuster JJ, Link M, et al. Significance of commonly used prognostic factors differs for childran with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 1999;13:1696-1707.
20. Goldberg JM, Silverman LB, Levy DE, et al. Childhood T-cell acute lymphoblastic leukamia: the Dana-Farber Cancer Institute acute lymphoblastic leukamia consortium experience. J Clin Oncol 2003;21:3616-3622.
21. Green DR, Evan GI. A mattar of life and death. Cancer Cell 2002;1:19-30.
22. Winter SS, Sweatman J, Shuster JJ, et al. Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. Leukemia 2002;16:1121-1126.
23. Niehues T, Kapaun P, Harms DO, et al. A classification based on T call selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies. Leukemia 1999;13:614-617.
24. Wuchter C, Ruppert V, Schrappe M, Dorken B, Ludwig WD, Karawajew L. In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia. Blood 2002;99:4109-4115.